THE WHAT? Kenvue has reported first-quarter 2026 gross sales and earnings progress, supported by improved execution, innovation and margin growth throughout its well being and sweetness portfolio.
THE DETAILS Kenvue reported a 4.5% enhance in web gross sales for Q1 2026, with natural gross sales rising 0.7% and diluted earnings per share growing 47% to US$0.25. Adjusted diluted EPS rose 33% to US$0.32. The corporate mentioned enhancements in gross revenue and working margins have been pushed by provide chain optimization initiatives, productiveness beneficial properties and value discount programmes. Pores and skin Well being and Magnificence delivered the strongest efficiency, with web gross sales growing 8.4% and natural gross sales up 5%, supported by improvements together with Neutrogena Solar Care growth in EMEA and the launch of OGX Professional Development. Important Well being gross sales rose 4.9%, pushed by progress in Child Care, Oral Care and Wound Care, whereas Self Care gross sales elevated 1.9% regardless of weaker chilly and flu seasons in main markets. Kenvue additionally confirmed progress on its deliberate acquisition by Kimberly-Clark, which is predicted to shut within the second half of 2026 pending regulatory approvals.
THE WHY? The outcomes show continued resilience within the well being, magnificence and private care sector regardless of macroeconomic uncertainty, whereas highlighting Kenvue’s give attention to operational efficiencies, innovation and portfolio strengthening forward of its merger with Kimberly-Clark.
Supply: Kenvue
